VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25626N0013
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $61,200
Award facts
- Contract value 100% obligated
- $61,199.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation has been awarded a Blanket Purchase Agreement (BPA) call valued at $61,199.60 for point-of-care whole blood glucose testing equipment and supplies to support Veterans Integrated Service Network (VISN) 16 locations. The contract operates under a firm fixed-price structure with a performance location in Castleton, Indiana, and extends through September 30, 2026. This award represents a child contract under the parent General Services Administration Schedule for In Vitro Diagnostics, Reagents, and Test supplies (FSS-65-VII) and was issued without set-aside designations, indicating open competition. The Department of Veterans Affairs VISN 16 will utilize this agreement to procure glucose monitoring technologies and related consumables for veteran patients across its service network facilities.
Roche Diagnostics Corporation, a foreign-owned diagnostics manufacturer headquartered in Indianapolis, maintains an extensive federal contracting presence across the Department of Veterans Affairs and Defense Health Agency. The company brings substantial experience delivering comprehensive laboratory and point-of-care testing solutions, including molecular diagnostics, histology systems, immunochemistry platforms, and glucose monitoring equipment. This VISN 16 award reflects Roche's ongoing role as a primary supplier of diagnostic capabilities to the federal healthcare system, consistent with the company's multiple active Indefinite Delivery Contracts and BPAs across numerous VISNs and military medical facilities. The modest contract value indicates this particular call represents a discrete ordering action under an established BPA vehicle rather than the full potential of the underlying agreement.
Quick answers
Who was awarded contract 36C25626N0013?
36C25626N0013 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C25626N0013 worth?
The government has obligated $61,200 on 36C25626N0013.
Is contract 36C25626N0013 an order under another contract?
Yes. 36C25626N0013 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25626N0013 competed?
The extent of competition for 36C25626N0013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award